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Mitral Regurgitation Severity and Left Ventricular Systolic
Dimension Predict Survival in Young Cavalier King Charles Spaniels
M.J. Reimann, J.E. Møller, J. H€aggstr€om, T. Martinussen, S.S.C. Zatrazemi, L. Svanholm,
L.B.M. Nielsen, H.D. Pedersen, and L.H. Olsen
Background: Development and progression of myxomatous mitral valve disease (MMVD) in dogs are diﬃcult to predict.
Identiﬁcation at a young age of dogs at high risk of adverse outcome in the future is desirable.
Hypothesis/Objectives: To study the predictive value of selected clinical and echocardiographic characteristics associated
with MMVD obtained at a young age for prediction of long-term cardiac and all-cause mortality in Cavalier King Charles
Spaniels (CKCS).
Animals: 1125 privately owned CKCS.
Methods: A retrospective study including CKCS examined at the age of 1–3 years. Long-term outcome was assessed by
telephone interview with owners. The value of variables for predicting mortality was investigated by Cox proportional hazard
and Kaplan-Meier analyses.
Results: Presence of moderate to severe mitral regurgitation (MR) (hazard ratio (HR) = 3.03, 95% conﬁdence interval
(95% CI) = 1.48–6.23, P = 0.0025) even intermittent moderate to severe MR (HR = 2.23, 95% CI = 1.48–6.23, P = 0.039)
on color ﬂow Doppler echocardiography was signiﬁcantly associated with increased hazard of cardiac death. An interaction
between MR and sex was signiﬁcant for all-cause mortality (P = 0.035), showing that males with moderate to severe MR
had a higher all-cause mortality compared to males with no MR (HR = 2.38, 95% CI = 1.27–4.49, P = 0.0071), whereas no
diﬀerence was found between female MR groups. The risk of cardiac (HR = 1.37, 95% CI = 1.14–1.63, P < 0.001) and all-
cause (HR = 1.13, 95% CI = 1.02–1.24, P = 0.016) mortality increased with increasing left ventricular end-systolic internal
dimension normalized for body weight (LVIDSN).
Conclusions and clinical importance: Moderate to severe MR, even if intermittent, and increased LVIDSN in dogs <3 years
of age were associated with cardiac death later in life in CKCS.
Key words: Dog; Heart failure; Myxomatous Mitral Valve Disease; Risk factor.
Myxomatous mitral valve disease (MMVD) is themost common cardiovascular disease in dogs with
a preponderance of middle- to old-aged, small-breed,
male dogs.1,2 MMVD is often regarded as a relatively
benign condition.3 However, in some dogs, the disease
will progress and cause congestive heart failure (CHF)
due to long-standing left ventricular and left atrial vol-
ume overload.3 Particularly, in the Cavalier King
Charles Spaniel (CKCS), MMVD is associated with
earlier onset and thus with potentially greater cardiac
morbidity and mortality compared to other breeds.4–6
Yet, the preclinical period often varies markedly
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BW body weight
CHF congestive heart failure
CI conﬁdence interval
CKCS Cavalier King Charles Spaniel
CV coeﬃcient of variation
FS fractional shortening
h/R diastolic LV posterior wall thickness relative to LV
internal diastolic radius
HR hazard ratio
LA/Ao left atrial-to-aortic root ratio
LVIDD left ventricular end-diastolic diameter
LVIDDN left ventricular end-diastolic diameter normalized for
BW
LVIDS left ventricular end-systolic diameter
LVIDSN left ventricular end-systolic diameter normalized for
BW
LV left ventricular
LVPWD left ventricular free wall thickness in diastole
MMVD myxomatous mitral valve disease
MR mitral regurgitation
MVP mitral valve prolapse
Standard Article
J Vet Intern Med 2017;31:1008–1016
between dogs making it challenging for clinicians to
identify dogs that will eventually succumb as a conse-
quence of the disease.3,7 Identiﬁcation of this subpopu-
lation of dogs at high risk of developing CHF,
preferably at an early age, would have a number of
advantages such as more targeted monitoring, and
owner education on recognition of clinical signs. As
studies indicate an inherited component to the disease
in at least some of the highly susceptible breeds, early
predictors would also allow for improved breeding rec-
ommendations.8–12 In addition, unnecessary owner con-
cern of short lifespan might be avoided for low-risk
dogs.3 Thus, it is of great interest to identify risk factors
and prognostic indicators associated with development,
progression, and survival of dogs with MMVD. Previ-
ously studies have proposed a number of clinical and
echocardiographic risk factors and prognostic indicators
aﬀecting survival.2,13–15 However, many of these studies
have been focusing on dogs at advanced stages of
MMVD and it has been found that many of the
echocardiographic variables do not change radically
until late stages of MMVD.16 Thus, information about
risk factors and prognostic indicators at an early age is
sparse.
The aim of the study was to investigate the predictive
value of selected clinical and echocardiographic charac-
teristics associated with MMVD for prediction of long-
term cardiac and all-cause mortality in CKCS before
the age of 3 years.
Materials and Methods
The medical records of all client-owned CKCS presented for
echocardiographic evaluation at the Department of Veterinary
Disease Biology, University of Copenhagen, between January 1,
1996, and June 30, 2012, were reviewed retrospectively.
Dogs between 1 and 3 years of age were evaluated for prebreed-
ing cardiac screening, cardiac health check, or participation in pre-
vious cross-sectional research projects. All owners provided
written or oral informed consent.
All dogs underwent owner interview, clinical examination, stan-
dardized echocardiographic examination, and electrocardiography
(ECG). The following clinical data were recorded: sex, age, coat
color, date of birth, body weight (BW), presence, and grade of
heart murmur. None of the dogs were sedated and owners were
present during the entire examination. Based on auscultation,
mitral regurgitation murmur intensity was graded 1–6.17 Intermit-
tent murmurs and physiological ﬂow murmurs (diagnosed as sys-
tolic murmurs with crescendo-decrescendo sound conﬁguration,
point of maximal intensity at the left heart base, and mild or no
concurrent MR found by color ﬂow Doppler echocardiography18)
were registered.
Echocardiography and Electrocardiography
Standardized transthoracic echocardiography with continuous
ECG monitoring from parasternal and apical windows19 including
2D, M-mode, and color ﬂow Doppler was performed on all dogs.
All examinations were performed by 2 experienced echocardiogra-
phers. Commercially available ultrasound unitsa and transducers
were used. If more than 1 echocardiographic examination had
been conducted before the age of 3, the most recent examination
was used for this study. Recorded echocardiograms were analyzed
oﬀ-line in a random order blinded for outcome of the dogs by 1
observer (MJR) either digitallyb or from videotape recordings
transferred to digital ﬁles. Images of inadequate quality were
excluded. The observer was blinded to all clinical data except date
of birth of the dog during analysis of echocardiograms. In ran-
domly selected dogs, measurements were repeated by the same
observer (6 times; n = 6 dogs) and by a second observer (LHO)
(n = 30). Severity of MR was assessed on color ﬂow Doppler
recordings from left apical four-chamber view and classiﬁed as no
(0%), mild (<20%), moderate (20–50%), severe (>50%), or inter-
mittent based on maximal systolic regurgitant jet area relative to
left atrial area.20 Intermittent MR was deﬁned as no or mild MR
in the majority of cardiac systoles but with some MR jets ≥20%.20
The degree of mitral valve prolapse (MVP) was evaluated from
the right parasternal long-axis four-chamber view and graded:
none (≤1 mm total MVP sum of anterior leaﬂet, posterior leaﬂet,
and coaptation point protrusion into LA in systole according to
annulus plane in increments of 1 mm), mild (2–4 mm), moderate
(5–7 mm), or severe (≥8 mm).20,21 Left atrial-to-aortic root ratio
(LA/Ao) was assessed from right parasternal short-axis view mea-
sured at ﬁrst frame after closure of the aortic valve at the level of
the aortic root as previously described.22 Left ventricular (LV)
dimensions were measured from the right parasternal short-axis
view using M-mode at the level of the chordae tendineae19: LV
end-diastolic and end-systolic internal dimensions (LVIDD,
LVIDS) and LV posterior wall thickness end-diastolic dimension
(LVPWD). Left ventricular internal dimensions were normalized
to body weight (BW)23 and fractional shortening (FS) was
calculated.24 The h/R ratio representing diastolic LV posterior wall
thickness (h = LVPWD) relative to LV internal diastolic radius
(R = LVIDD/2) was calculated as described elsewhere.25 All quan-
titative echocardiographic variables were based on mean of 3 mea-
surements. Heart rate was recorded from a separate ECG paper
recording that was performed after the initial part of the echocar-
diographic examination with the dog in right lateral recumbency
by counting number of R–R intervals per 15 seconds.
Follow-Up
Standardized telephone interviews were conducted between
December 1, 2012, and June 30, 2013, with dog owners to deter-
mine the current health status of each dog. Dogs between 1 and
3 years that had been echocardiographically examined at the
Department of Veterinary Disease Biology, University of Copen-
hagen, within the last year (between June 30, 2012, and June 30,
2013) were not included as health status was considered the same
as at the last examination. Likewise, owners of older dogs that
had been re-examined at the Department of Veterinary Disease
Biology, University of Copenhagen, within the last year were not
contacted, but instead information from the medical records was
used as health status was considered the same as at their last
examination. A questionnaire with a number of predeﬁned possi-
ble answers modiﬁed from Borgarelli et al.3,15 was used. The inter-
viewer was blinded to the clinical status of the dog at the initial
examination. The owner was asked whether the dog was dead or
alive. If the dog was dead, the owner was asked at what age death
had occurred, whether the dog had been euthanized or died spon-
taneously, cause of death/reason for euthanasia, whether the dog
had received cardiac treatment (including period of time receiving
cardiac treatment and clinical eﬀect), and whether the dog had
clinical signs of CHF (including dyspnoea, breathlessness, noctur-
nal restlessness, frequent coughing, exercise intolerance, and syn-
cope). Dogs were then allocated into the following groups
depending on presumed cause of death: cardiac death or noncar-
diac death. Cardiac death was deﬁned as death or euthanasia due
to clinical signs of CHF or diagnosis of CHF by local veterinarian
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with or without diagnostics and response to cardiac treatment,
sudden death with no other evident cause, death in anesthesia with
previous cardiac signs, or euthanasia by authors due to refractory
CHF. Sudden death was deﬁned as death occurring within 1 hour
after onset of clinical signs or a dog found dead by owner when
arriving home. All other deaths were recorded as noncardiac-
related.
Statistical Analysis
Statistical softwarec was used for data analysis and a P value of
<0.05 was considered signiﬁcant unless otherwise stated.
For descriptive statistics, dogs were divided into 4 groups: those
that were alive, those dead due to heart disease, those dead due to
other causes, and those that were lost to follow-up. Data are
reported as medians and interquartile ranges.
By Cox proportional hazard analysis, the eﬀects on survival of
the following variables were evaluated: sex, body weight (BW),
coat color, MR group, MVP group, murmur, heart rate, LA/Ao,
LVIDD normalized for BW (LVIDDN), LVIDS normalized for
BW (LVIDSN), LVPWD, FS, and h/R. Age was used as timescale
with entry at 3 years of age (delayed entry), ensuring that all dogs
have the measurements performed. Dogs that were alive at the end
of the study period were right-censored. For the purpose of statis-
tical analysis, the following groups were combined due to low
numbers: MR groups moderate (n = 118) and severe (n = 8) to
group MR moderate-severe, MVP groups moderate (n = 183) and
severe (n = 10) to group MVP 2, and ﬁnally murmur groups 1
(n = 23), intermittent 1 (n = 5), 2 (n = 19), and 3–6 (n = 0) to
group murmur >0. The primary endpoints of the study were death
and analyses were performed for all-cause and cardiac death. Dogs
dying from a combination of 2 or more causes (including a cardiac
related cause) (n = 14) are listed as “combined” and thus are not
included in statistical analysis as cardiac deaths.
Because the study was performed over several years, a period
variable with 3 categories (1996–2001, 2002–2007, and 2008–2012)
indicating the date of echocardiography was constructed. All sig-
niﬁcant variables in the 2 Cox proportional hazard analyses (the 1
for all-cause and the 1 for cardiac death) were tested for interac-
tions with the period variable, but none were found.
For descriptive purposes, univariate Cox proportional hazard
analyses were performed. The primary analyses was multivariate
Cox proportional hazard analyses including relevant interactions
(sex*MR group, sex*MVP group, and sex*murmur group). A
combination of forward inclusion and backward elimination was
applied to form a ﬁnal model. The proportional hazards assump-
tion as well as the assumption of log-linear eﬀect of continuous
explanatory variables was investigated using cumulative martingale
residuals.26
By the Kaplan-Meier method, survival curves and median sur-
vival times with 95% conﬁdence intervals (95% CI) were estimated
for all-cause mortality.
The obtained multivariate Cox proportional hazard model for
cardiac death was used to construct cumulative incidence curves
for diﬀerent combinations of MR and sex and all other variables
that proved signiﬁcant for mortality in the multivariable analyses
set at their median values.
Diﬀerences between all variables for follow-up dogs and dogs
lost to follow-up were tested by logistic regression using the vari-
able lost to follow-up (yes/no) as response variable (see Table S1).
Inter- and intraobserver variability coeﬃcients of variation are
also included in Table S2.
Results
The study population included a total of 1125 CKCS.
Figure 1 illustrates the exclusion of dogs. Baseline char-
acteristics and echocardiographic values of the ﬁnal
Postanalysis exclusion(n=72):
Follow-up interview before 3 years of age (n=62)
Death before 3 years of age (n=10)
Post-follow-up exclusion (n=121):
Insufficient info concerning age of death (n=2)
Insufficient info concerning cause of death (n=5)
Lost to follow-up (n=114)
Pre-follow-up exclusion (n=26):
Pregnancy (n=5)
Nonvalvular heart disease (n=14)
Cardiac therapy (n=1)
No pedigree (n=6)
Medical records
1996-2012
(n=1125)
Final study population
(n=906)
Fig 1. Flowchart illustrating reasons for exclusion of study dogs.
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study population are listed in Table 1. Of the 906
CKCS that had their status recorded, 288 died or were
euthanized during the follow-up period. Of these 74
(26%) were considered cardiac deaths. Of the 74 cardiac
deaths, 31 (42%) died a sudden death (15 males and 16
females). There were 214 (74%) CKCS that died/were
euthanized due to noncardiac causes. The median per-
iod of follow-up was 3.1 years (quartile 1-quartile 3,
1.5–5.4). Figures 2 and S1 show the diﬀerent causes of
death in males and females.
Survival Analyses
Table 2 shows univariable predictors of all-cause
mortality and cardiac death.
Based on the results from univariable analysis, the
following variables were considered for multivariable
modeling: LVIDSN, LA/Ao, FS, heart rate, MR group,
MVP group, and sex. Collinearity (Spearman’s correla-
tion of 0.59) was found between FS and LVIDSN. As
LVIDSN was the best predictor concerning cardiac
Table 1. Dog characteristics and conventional echocardiographic variables for 1020 CKCS allocated according out-
come in 2013.
Variable n Alive (1) Cardiac death (2) Non-cardiac death (3) Lost to follow-up (4)
Number of CKCS 1020 618 74 214 114
Age at examination (days) 1020 640 (571;749) 745 (603;914) 726 (597;863) 650 (563;844)
Sex (f/m) 1020 404/214 41/33 137/77 72/42
Color (bh, bt, rb, tri) 1020 217/146/124/131 30/11/10/23 84/31/33/66 42/17/23/32
BW (kg) 1020 8.2 (7.3;8.3) 8.4 (7.4;9.6) 8.2 (7.4;9.3) 8.4 (7.2;9.6)
MR (no/mild/mod-se/int) 1015 282/200/63/72 15/27/16/14 70/83/23/36 41/38/24/11
MVP (0/1/2) 1017 68/430/119 16/42/16 26/155/32 9/78/26
Murmur (0/>0/f) 1020 570/11/37 57/11/6 164/18/32 92/7/15
Heart rate (beats/min) 968 120 (102;144) 120 (102;132) 114 (102;132) 120 (102;141)
LA/Ao 1002 1.2 (1.1;1.3) 1.2 (1.1;1.2) 1.2 (1.1;1.2) 1.1 (1.0;1.2)
LVIDDN 1015 1.5 (1.4;1.5) 1.4 (1.3;1.5) 1.4 (1.3;1.5) 1.4 (1.3;1.5)
LVIDSN 1015 0.9 (0.9;1.0) 1.0 (0.9;1.0) 0.9 (0.8;1.0) 0.9 (0.8;1.0)
LVPWD 1015 0.7 (0.6;0.8) 0.7 (0.6;0.8) 0.7 (0.6;0.8) 0.7 (0.6;0.8)
FS (%) 1015 32.7 (28.6;36.3) 30.6 (27.6;36.0) 32.4 (28.3;37.1) 32.4 (28.0;37.7)
h/R 1015 0.5 (0.5;0.6) 0.5 (0.5;0.6) 0.5 (0.5;0.6) 0.5 (0.5;0.6)
BW, body weight; CKCS, Cavalier King Charles Spaniels; color, coat color where bh, blenheim; bt, black and tan; rb, ruby, tri, tricolor;
FS, fractional shortening; h/R, LV posterior wall thickness relative to internal diastolic radius; LA/Ao, ratio of left atrium to aortic root;
LVIDDN, left ventricular end-diastolic diameter normalized for BW; LVIDSN, left ventricular end-systolic diameter normalized for BW;
LVPWD, left ventricular free wall thickness in diastole; MR, mitral regurgitation group where no = no (0%), mild, mild (<20%), mod-se,
moderate-severe (20–100%), int, intermittent (most often mild MR but some MR jets ≥ 20%); MVP, mitral valve prolapse group where
0 = ≤1 mm total MVP, 1 = 2-4 mm total MVP, 2 = ≥5 mm total MVP; murmur, mitral regurgitation murmur intensity group where
0 = no murmur, >0 = murmur 1–6, f = ﬂow murmur. Values reported are median and interquartile ranges.
Fig 2. Histogram showing causes of death in the 288 CKCS. Other includes: old age (males = 2; females = 9), toxic (males = 1;
females = 3), endocrinology (males = 2; females = 0), gastrointestinal (males = 3; females = 1), unspeciﬁed (males = 2; females = 7), anes-
thesia without previous cardiac clinical signs (males = 0; females = 3), ocular (males = 4; females = 3), immune-mediated (males = 0;
females = 4), auditory and integument (males = 2; females = 1), respiratory (males = 1; females = 1), kidney/liver/pancreas (males = 2;
females = 10), iatrogen (males = 1; females = 0), combination of 2 or more categories including cardiovascular (males = 5; females = 9),
combination of 2 or more categories excluding cardiovascular (males = 4; females = 12).
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death, this variable was chosen for multivariate analy-
sis. A statistically signiﬁcant interaction between MR
group and sex was found. All multivariable analyses
(all-cause and cardiac mortality) were performed includ-
ing the explanatory variables: LVIDSN, LA/Ao, heart
rate, MVP group, and the interaction between MR
group and sex. When adjusting for the other explanatory
variables, heart rate and MVP group were no longer
signiﬁcant for all-cause or cardiac mortality, Table 3.
A higher value of LVIDSN at examination between 1
and 3 years of age signiﬁcantly increased the hazard of
cardiac and all-cause mortality. Dogs with moderate to
severe MR and intermittent MR had signiﬁcantly
increased hazard of cardiac death compared to dogs
with no MR. Counterintuitively, a lower value of LA/
Ao at examination between 1 and 3 years of age signiﬁ-
cantly increased the hazard of cardiac and all-cause
mortality.
The interaction between MR group and sex was sig-
niﬁcant for all-cause mortality but not cardiac death.
Males with moderate to severe MR had signiﬁcantly
increased hazard ratio of death compared to males with
no MR (hazard ratio = 2.38, 95% CI = 1.27–4.49,
P = 0.0071) whereas there was no signiﬁcant diﬀerences
between MR groups for females, Fig. 3.
Figure 4 shows cumulative incidence curves for
cardiac death, demonstrating that having moderate to
severe MR at 1–3 years age or presence of
Table 2. Results of univariable Cox proportional hazard analyses of factors predictive for survival (all-cause and
cardiac mortality) in 906 CKCS.
All-Cause Mortality Cardiac Death
n/Number of Events HR (95% CI) P n/Number of Events HR (95% CI) P
MR group 901/284 901/72
mild vs. no 0.95 (0.72;1.27) 0.75 1.30 (0.69;2.44) 0.42
mod-se vs. no 1.25 (0.86;1.83) 0.24 2.81 (1.39;5.69) 0.0041
int vs. no 1.11 (0.78;1.58) 0.57 1.72 (0.83;3.56) 0.15
MVP 904/287 904/74
1 vs. 0 1.08 (0.77;1.51) 0.66 0.60 (0.34;1.08) 0.087
2 vs. 0 1.38 (0.91;2.12) 0.13 1.20 (0.59;2.44) 0.61
Murmur 906/288 906/74
>0 vs. 0 0.91 (0.61;1.35) 0.63 1.27 (0.66;2.45) 0.48
f vs. 0 1.21 (0.86;1.71) 0.28 0.69 (0.30;1.60) 0.38
Heart rate 863/275 0.99 (0.99;1.00) 0.021 863/71 1.00 (0.99;1.01) 0.88
Sex (males) 906/288 1.15 (0.90;1.46) 0.263 906/74 1.44 (0.91;2.27) 0.12
Color 906/288 906/74
Bt vs. Bh 0.86 (0.60;1.23) 0.41 0.87 (0.44;1.74) 0.70
Rb vs. Bh 0.99 (0.69;1.41) 0.95 0.97 (0.47;1.98) 0.93
Tri vs. Bh 1.16 (0.88;1.54) 0.29 1.09 (0.63;1.88) 0.76
BW 906/288 1.01 (0.94;1.09) 0.80 906/74 1.02 (0.88;1.18) 0.78
LA/Ao 894/285 0.36 (0.098;1.35) 0.13 894/74 0.12 (0.0093;1.58) 0.11
LVIDDN 901/285 1.03 (0.95;1.11) 0.50 901/74 1.12 (0.96;1.29) 0.14
LVIDSN 901/285 1.14 (1.04;1.25) 0.0052 901/74 1.33 (1.12;1.57) 0.0010
LVPWD 901/285 0.96 (0.86;1.08) 0.51 901/74 0.88 (0.70;1.10) 0.26
FS 901/285 0.96 (0.94;0.98) <0.001 901/74 0.93 (0.90;0.97) <0.001
h/R 901/285 0.76 (0.21;2.73) 0.68 901/74 0.15 (0.011;2.01) 0.15
BW, body weight; CKCS, Cavalier King Charles Spaniels; color, coat color where bh, blenheim; bt, black and tan; rb, ruby; tri, tricolor;
FS, fractional shortening; h/R, LV posterior wall thickness relative to internal diastolic radius; LA/Ao, ratio of left atrium to aortic root;
LVIDDN, left ventricular end-diastolic diameter normalized for BW; LVIDSN, left ventricular end-systolic diameter normalized for BW;
LVPWDN, left ventricular free wall thickness in diastole normalized for BW; MR, mitral regurgitation group where no = no (0%), mild,
mild (<20%), moderate-se, moderate-severe (20–100%), int, intermittent (most often mild MR but some MR jets ≥20%); MVP, mitral
valve prolapse group where 0 = ≤1 mm total MVP, 1 = 2–4 mm total MVP, 2 = ≥5 mm total MVP; murmur, mitral regurgitation murmur
intensity group where 0 = no murmur, >0 = murmur 1–6, f = ﬂow murmur. Bold values are statistically signiﬁcant.
Table 3. Results of multivariable Cox proportional
hazard analyses of factors predictive of survival in 906
CKCS.
Variable
All-cause mortality Cardiac death
HR (95% CI) P HR (95% CI) P
LVIDSN 1.13 (1.02;1.24) 0.016 1.37 (1.14;1.63) <0.001
LA/Ao 0.17 (0.044;0.68) 0.012 0.045 (0.0030;0.69) 0.026
MR*sex – 0.035 – 0.99
MR group – – 1.51 (0.78;2.90) 0.22
mild
vs. no
3.03 (1.48;6.23) 0.0025
mod-se
vs. no int
vs. no
2.23 (1.04;4.79) 0.039
95% CI, 95% conﬁdence interval; HR, hazard ratio; LA/Ao,
ratio of left atrium to aortic root; LVIDSN, left ventricular end-
systolic diameter normalized for BW; MR, mitral regurgitation
group where no = no (0%), mild, mild (<20%), moderate-se, mod-
erate-severe (20–100%); int, intermittent (most often mild MR but
some MR jets ≥20%). Bold values are statistically signiﬁcant.
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intermittent MR is associated with increased risk of
cardiac death.
Discussion
The results of the present study show that presence
of more than mild MR even if intermittent on echocar-
diography in CKCS aged 1–3 years was associated with
increased risk of cardiac death. This was especially true
for male dogs. Finally, even though MMVD generally
is considered a relatively benign condition, a relatively
large proportion (more than one-fourth) of the CKCS
deaths in the present study were due to cardiac causes.
To minimize variability, the present study followed a
standardized protocol at the same research facility and
only very few operators and observers were included.
Furthermore, a large number of dogs were included and
all dogs were of the same breed. Surprisingly, only few
variables were predictive of mortality. Yet, this is prob-
ably in part due to the very young age at which the
dogs were examined.
As expected, more severe MR at examination at
young age was associated with increased cardiac mortal-
ity in CKCS. This was however not the case when MR
was based on murmur intensity on auscultation under-
lining the importance of assessment of MR using car-
diac ultrasound.15,18 In accordance with the present
study, previous studies evaluating murmur intensity also
found limited prognostic signiﬁcance of low-grade
murmurs.27,28 In the present study, ﬂow murmurs do
not appear to have any prognostic signiﬁcance either.
There are a number of ongoing breeding programs
aimed at decreasing the prevalence of MMVD in CKCS
in several diﬀerent countries.12,29,30 These programs are
mostly based on identiﬁcation of MR using auscultation
but some also include echocardiography (estimating the
degree of MVP) and parental information. A recent
study concerning the Danish breeding program for
CKCS based on auscultation and echocardiography did
ﬁnd a decrease in prevalence of MMVD; however, it
was unclear whether auscultation, echocardiography (es-
timating the degree of MVP), or the fact that the pro-
gram was mandatory contributed most to this eﬀect.12
Yet, based on the results from the present study, it
could seem that adding echocardiographic information
estimating the degree of MR to the breeding evaluation
Fig 3. Kaplan-Meier curves for all-cause mortality given for each
combination of sex (top = females, bottom = males) and mitral
regurgitation (MR) group where black curve represents no
MR = 0%, red curve represents mild MR (<20%), green curve
represents moderate (20–50%)-severe (>50%) MR, and blue curve
represents intermittent MR (most often mild MR but some MR
jets ≥20%).
Fig 4. Cumulative incidence curves for cardiac death given for
each combination of sex (top = females, bottom = males) and
mitral regurgitation (MR) group where black curve represents no
MR = 0%, red curve represents mild MR (<20%), green curve
represents moderate (20–50%)-severe (>50%) MR, and blue curve
represents intermittent MR (most often mild MR but some MR
jets ≥ 20%). The remaining variables are set at their median values
(LVIDSN = 0.93, LA/Ao = 1.2, and HR = 120).
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might be useful. It is important to be aware of the fact
that color ﬂow Doppler echocardiography is a semi-
quantitative estimate inﬂuenced by factors such as
echocardiographic equipment and technical settings.31
However, other methods of estimating MR size such as
calculation of the eﬀective regurgitant oriﬁce area
(EROA) using the proximal isovelocity surface area
(PISA) or vena contracta are not always possible to
achieve in mild cases of MR.
Interestingly, presence of echocardiographic intermit-
tent MR was also associated with increased cardiac
mortality. The nature of intermittent MR is generally
poorly characterized and the clinical importance of this
phenomenon has not previously been studied in dogs20
and has not been described in human patients. A sur-
prising and interesting ﬁnding was that intermittent MR
but not mild MR was associated with cardiac mortality,
considering that the MR in intermittent MR was mild
in most heart beats. A possible explanation might be
that the single heart beats with more severe MR medi-
ates valvular shear stress that inﬂuences disease progres-
sion or that the atrium cannot handle the more severe
MRs that suddenly occur. A previous study found
intermittent MR to be associated with variations in
R–R interval.20 Thus, another hypothesis is that inter-
mittent MR might represent moderate or severe MR
masked by a variation in R–R interval or heart rate.
These hypotheses would imply that intermittent MRs
should be considered as serious as the maximal MR
observed instead of the MR that is most often
observed. Thus, intermittent MR or intermittent mur-
murs might be warning sign that warrant more close
surveillance of a patient. It is unknown whether the size
of the intermittent MR is important in relation to pro-
gression of MMVD, and whether intermittent MR is an
early manifestation of progression to more advanced
MR. Thus, further studies are needed to clarify the
importance of this phenomenon.
The fact that MR group (as an interaction with sex)
was also associated with all-cause mortality may seem
odd, but it probably is a consequence of the relation-
ship between cardiac death and all-cause mortality.
In dogs with MMVD, previous studies have sug-
gested MVP to have prognostic signiﬁcance.27,28,32 The
fact that MVP was not associated with survival in the
present study does not imply that MVP should not be
used as an early risk factor for MMVD and cardiac
death. As the vast majority of the CKCS had some
degree of MVP, and relative few dogs had no or severe
MVP, it can be diﬃcult to show signiﬁcant diﬀerences
associated with MVP. Furthermore, in the present
study, the consequences of MVP (which is MR) did
have prognostic signiﬁcance.
Higher LVIDSN (and lower FS) was associated with
a higher all-cause and cardiac mortality. This is an
interesting ﬁnding. It may be hypothesized that this
ﬁnding could indicate a systolic dysfunction at a very
early age in CKCS. However, the clinical signiﬁcance of
the ﬁnding remains uncertain as the values of both
LVIDSN and FS were generally within reference ranges
of normal dogs13,20,33 Previous studies have found
systolic LV dimensions to have predictive value for sur-
vival, but to the authors knowledge, this has not be
evaluated previously in CKCS this young.3,16,25,34 In
human patients with MR, severe LV dilatation with
increased chamber dimensions is associated with poor
prognosis and considered important for timing of surgi-
cal intervention.35
Decreased LA/Ao ratio was also found to be associ-
ated with a higher all-cause and cardiac mortality. This
was not expected and counterintuitive as it is generally
accepted that increasing LA/Ao is a risk factor in
MMVD.3,13,15,36 Again, it should be kept in mind that
the dogs are very young and that all LA/Ao values were
within a very narrow range and all within reference
ranges of normal dogs37 and thus could represent a
ﬁnding occurring at random.
Myxomatous mitral valve disease generally is consid-
ered a relatively benign condition. Yet, in the present
study a relatively large proportion of the CKCS deaths
were due to cardiac causes (26%). In the present study,
life time could not be estimated as dogs were included
at the age of 3, meaning that the life time would be
overestimated as dogs dying before 3 years of age were
excluded. However, data suggested (Fig 4) that cardiac
mortality does not begin to increase before the age of
7 years and that many dogs survive longer than that. In
addition, we found that dogs with moderate to severe
MR even when intermittent had increased risk of death
and that this was especially true for male dogs. This is
in accordance with previous studies indicating that
MMVD in male dogs is more common and progress
faster.8,9,38 Further, data suggest (Fig 3) that males
have a trend toward higher all-cause mortality rate with
approximately 60% of male CKCS dying before the age
of 10 years compared to only approximately 50% of
the females.
Generally, the dogs lost to follow-up were dogs that
changed owner. There were diﬀerences in few echocar-
diographic measurements between CKCS included in
survival analysis and CKCS lost to follow-up (see
Table S1). This comparison was made to assess for
selection bias. It is unclear how this may have inﬂu-
enced our ﬁndings.
Limitations of the study include selection bias as dogs
were privately owned and chosen from a database of
CKCS used primarily for breeding purposes. This is
also the reason that more female CKCS were included
compared to males.
Furthermore, due to the retrospective nature of the
present study, it was challenging to classify cause of
death (based primarily on owner statements) and a pro-
portion of the deaths may have been inaccurately classi-
ﬁed. Many dogs had died a long time ago and many
owners had more than 1 dog, and thus, it may have
been a problem for the owner to remember the actual
circumstances. In addition, in the majority of the cases,
the diagnosis was based on ﬁndings from the owners’
local veterinarian and often diagnoses were quite
unspeciﬁc and/or based on only few diagnostic tests.
Clinical signs are often diﬃcult to diﬀerentiate from
other conditions of elderly dogs and coughing and
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exercise intolerance may as well be a sign of bronchitis
and osteoarthritis. Often the decision to euthanize a
dog is multifactorial and the extent to which heart dis-
ease played a part is impossible to determine. In the
present study, CKCS euthanized because of a combina-
tion of cardiac signs and other problems (n = 14) were
assigned to a “combined causes” category and thus did
not ﬁgure as cardiac deaths. Similarly, 2 dogs were
euthanized because of a poor result at their prebreeding
cardiac examination and these dogs were assigned to
the “owner/behavior” category (see Fig 2). A number
of CKCS were euthanized because of neurologic signs
that the local veterinarian assigned to epilepsy, cerebral
hemorrhage, or thrombosis. These signs could be misdi-
agnosed syncope or results of cardiac disease as throm-
bus formation is a known complication of heart disease.
Therefore, it could be argued that these dogs should
have been categorized as cardiac deaths. In contrast,
other diseases than heart disease without previous clear
signs might have resulted in sudden death (i.e, subclini-
cal neoplasia or intracranial problems), thus causing
overestimation of cardiac related death. In the present
study, it was not possible to diﬀerentiate types of car-
diac disease in this study, but given the high prevalence
of MMVD in CKCS, it is assumed that the majority of
cardiac deaths were due to MMVD.1,4
An additional limitation is the eﬀect of time that may
have inﬂuenced results in several ways. All oﬀ-line
echocardiographic analyses were performed by a single
observer. Furthermore, no interactions were found with
the period variable and any of the signiﬁcant variables
in the Cox proportional hazard analyses. However, the
operators performing auscultation and echocardiogra-
phy (even though they were highly experienced) and
echocardiographic equipment did change few times over
time. This is especially of concern for color ﬂow Dop-
pler echocardiography which is a semiquantitative esti-
mate inﬂuenced by a number of factors such as
echocardiographic equipment, technical settings, ﬂow
direction, and blood pressure.31,39
Estimation of MR by the jet area method with color
ﬂow Doppler echocardiography is not optimal. How-
ever, gold standard methods requiring anesthesia of the
dog, for example, cardiac magnetic resonance imaging
were not possible in the present study.
Diﬀerentiation between intermittent MR and mild
MR can be very challenging because movement of the
heart during systole might change the plane of scan,
and thus, mild MRs can disappear from the plane of
scan and appear to be intermittent. Various apical
planes are therefore beneﬁcial to grade MR. However,
the recordings available in the present study did not
permit for more planes to be included in the echocar-
diographic evaluation. Further prospective studies are
needed to clarify the presence and signiﬁcance of inter-
mittent MR.
Finally, the diﬀerent follow-up times of the dogs
caused by the study design and fact that an ongoing
breeding program with documented eﬀect12 was being
carried out simultaneously may have inﬂuenced
results.
Conclusions
The present study indicates that presence of moderate
to severe MR, intermittent moderate to severe MR, and
increased LV systolic dimensions at 1–3 years of age
are associated with increased cardiac mortality in
CKCS later in life. Flow murmurs and mild MR did
not inﬂuence cardiac mortality.
Footnotes
a Aloka SSD-2200 (January 1, 1996–December 31, 2000); Vivid 3
echocardiograph, GE-medical, Milwaukee, Wisconsin, USA (Jan-
uary 1, 2001–July 15, 2008) and Vividi echocardiograph, GE-
medical, Milwaukee, Wisconsin, USA (July 16, 2008–July 30, 2013)
b EchoPAC PC. Version 112, GE Vingmed Ultrasound AS, Hor-
ten, Norway.
c R studio, version 0.97.336, © 2009–2012 RStudio, Inc., Boston,
Massachusetts
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Supporting Information
Additional Supporting Information may be found
online in the supporting information tab for this article:
Figure S1. Causes of death in 288 CKCS plotted
according to age. Other includes: old age (males = 2;
females = 9), toxic (males = 1; females = 3), endocrinol-
ogy (males = 2; females = 0), gastrointestinal
(males = 3; females = 1), unspeciﬁed (males = 2;
females = 7), anesthesia without previous cardiac clini-
cal signs (males = 0; females = 3), ocular (males = 4;
females = 3), immune-mediated (males = 0;
females = 4), auditory and integument (males = 2;
females = 1), respiratory (males = 1; females = 1), kid-
ney/liver/pancreas (males = 2; females = 10), iatrogen
(males = 1; females = 0), combination of 2 or more cat-
egories including cardiovascular (males = 5;
females = 9), combination of 2 or more categories
excluding cardiovascular (males = 4; females = 12). In 2
dogs the age of death was unknown.
Table S1. Statistically signiﬁcant results of logistic
regression analyses between follow-up dogs and dogs
lost to follow-up.
Table S2. Inter- and intraobserver variability coeﬃ-
cients of variation of the echocardiographic variables.
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